R2-MTX
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for R2-MTX, covering 2020-06-05 to 2020-06-05. Get the full timeline:
Most recent: Clinical Trial Update: R2-MTX With Lenalidomide Maintenance in Newly-diagnosed PCNSL：a Multicenter Phase Ib/II Stuty [Phase 1, Phase 2]